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ABSTRACT 
Gorlin-Goltz Syndrome also known as Nevoid Basal Cell Carcinoma 
Syndrome is an autosomal dominant multisystem disorder.  It is 
characterized by basal cell carcinomas, odontogenic keratocysts, skeletal 
abnormalities and in a minority of female patients bilateral calcified ovarian 
fibromas. It is challenging to radiologically assess ovarian fibromas as they 
have similar imaging patterns to some malignant ovarian lesions. However, it 
is vitally important to differentiate between benign and malignant lesions to 
determine patients' suitability for fertility-sparing surgery. This report 
describes a case of a 25 year-old patient with Gorlin-Goltz Syndrome and 
bilateral ovarian fibromas. 
 
 
 
CASE REPORT 
 
 
 
 
 
A 25-year-old Caucasian woman underwent gynecological 
examination for irregular menses. Blood tests were normal 
apart from a slightly raised prolactin (56 ng/ml; normal ranges 
0-23 ng/ml). 
 
Transrectal ultrasound imaging (US) had highlighted the 
presence of several uterine and ovarian hypoechoic masses; 
the largest one between uterus and bladder (Figure 1), 
measuring 65 x 62 x 59 mm, was adherent to anterior uterine 
wall, with heterogenous vascularization. Left ovary was 
appreciable with difficulty due to the presence of a rounded 
hypoechoic mass measuring 18 x 15 mm. Ovarian follicles 
were not depictable bilaterally. These findings required further 
evaluation with Magnetic Resonance Imaging (MRI) of the 
pelvis. 
 
MRI detected multiple round-shaped lesions in both 
ovaries and uterus, the largest one in the left adnexa (67 x 73 x 
55 mm); all the lesions had a similar appearance with a 
heterogenous signal on the T2-weighted sequences, mild 
diffusion restriction on diffusion weighted sequence and 
intense heterogenous contrast-enhancement after Gadolinium 
administration (Figure 2, Figure 3, Figure 4, Figure 5). The 
patient also had adjacent lymphadenopathy and intraperitoneal 
fluid. These findings were suspicious of malignant lesions and 
a staging computed tomography (CT) examination was 
performed.  
 
CT confirmed the presence of the numerous uterine and 
ovarian masses, some of which contained calcific foci, but no 
additional lesions were found in either the thorax or abdomen. 
A possible differential diagnosis was multiple fibromatosis of 
the uterus and ovaries, even though some of ovarian masses 
could not be differentiated radiologically from fibrothecomas 
or ovarian germ-cell tumors (Figure 6). 
 
Upon further questioning, the patient revealed a history of 
multiple basal cell carcinomas (BCCs), the last one had been 
excised on the right thigh 4 years prior to presentation, and of 
an odontogenic cyst, surgically removed 9 years prior to 
presentation. The patient underwent laparascopic fertility-
sparing surgery of the ovarian and uterine masses (Figure 7).  
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Histological analysis confirmed small aggregates of 
fibroblast cells without cytologic atipies, consistent with the 
diagnosis of NBCCS given the patient’s medical history 
(Figure 8). 
 
 
 
 
Etiology & Demographics: 
Gorlin-Goltz Syndrome also known as Nevoid Basal Cell 
Carcinoma Syndrome (NBCCS) is a rare multisystem disease. 
It is caused by mutations in the PTCH1 gene and is autosomal 
dominant with complete penetrance and variable expressivity. 
This syndrome has several names, but we will use NBCCS, as 
suggested by Professor Gorlin [1]. Patients and their relatives 
often use the name “Gorlin Syndrome”, as it does not contain 
the word “carcinoma”, even if approximately 50 % of patients 
will develop skin cancers [2]. 
 
The estimated prevalence of NBCCS varies from 1/57,000 
to 1/256,000 and it commonly appears in adolescence. There 
is no difference in the prevalence between males and females; 
however, those affected are predominantly Caucasians [3]. 
 
Clinical & Imaging Findings: 
NBCCS is associated with basal cell carcinomas, 
odontogenic keratocysts (that generally develop during first to 
third decades), palmar and/or plantar pits and ectopic 
calcifications of the falx cerebri [2].  
 
This syndrome is a clinical and radiological diagnosis 
with the presence of 2 major criteria and 1 minor criterion or 1 
major and 3 minor criteria, as suggested by the first 
classification of Evans et al in 1993 [4], recently updated by 
the same authors in March 2018 [5] (Table 1), who highlighted 
that no study has been able to assess which combination of 
diagnostic criteria represents the best trade-off between 
sensitivity and specificity. If clinical features are inconclusive, 
to establish the diagnosis, the identification of heterozygous 
germline PTCH1 is necessary. 
 
Early diagnosis of NBCCS is crucial due to the risk of 
developing malignancies such as medulloblastoma and 
aggressive skin cancers. Medulloblastoma is screened for in all 
patients with NBCCS as early diagnosis can improve outcomes 
[1]. 
Clinical history of our patient revealed the presence of 2 
major criteria (basal cell carcinomas and odontogenic 
keratocysts) and 1 minor criteria (ovarian fibromas).  
 
It is difficult to know the frequency of ovarian fibromas in 
NBCCS as they do not present unless they become multiple, 
large, calcified or twist on their pedicles. A population-based 
study, performed in the early 90s, suggests a frequency of 
25%. Ovarian fibromas associated with NBCCS are most often 
bilateral (75%), calcified and nodular, often overlapping 
medially, eventually erroneously diagnosed as calcified uterine 
leiomyomas [6]. Ovarian fibromas not associated with this 
syndrome are often unilateral and calcified only in 10% of 
cases. Rarely, the tumor may be virilizing or renin secreting 
[6]. In our case, there was no raise of renin but a mild 
hyperprolactinemia, which is known to be associated with 
large uterine fibromas [7]. 
 
Sonography is generally used as the first-line imaging 
technique for the evaluation of ovarian pathologic 
abnormalities; nonetheless their sonographic features are often 
non-specific, therefore MRI is often needed for further 
differentiation [8]. 
 
On Ultrasound, fibromas most commonly manifest as 
solid, hypoechoic masses with sound attenuation. However, 
the US appearance is variable, and hyperechoic masses with 
increased through-transmission may be seen [9].  
 
On CT, fibromas manifest as diffuse, slightly 
hypoattenuating masses; unlike most other solid masses, 
fibromas show poor, very slow enhancement with 
administration of contrast material [9]. 
 
MR is an excellent imaging modality for studying female 
pelvis and permits detection and excellent characterization of 
uterine and ovarian masses [8]. Ovarian fibromas in 
conventional MR imaging studies are characterized by low to 
intermediate signal intensity on T1-weighted images and low 
signal intensity on T2-weighted images caused by densely 
packed connective tissue.  
 
MRI features of fibromas and fibrothecomas depend on 
the size of the lesion because the lesions measuring more than 
60 mm can mimic malignant ovarian tumors as they present as 
solid adnexal masses sometimes associated with a 
pseudocapsule, degenerative changes, oedema, and peripheral 
subcapsular cystic areas. This explains the varying degree of 
high intensity portions on T2-weighted images and slow 
heterogenous enhancement [8, 10]. Only hemorrhage within 
the lesions would be characterized by the appearance of high 
signal intensity on T1-weighted images and heterogenous low 
and high signal mixed intensity on T2-weighted images [11]. 
 
On T2-weighted images fibromas and thecomas with a 
fibrotic component appear as well-circumscribed masses with 
low signal intensity containing scattered high-signal intensity 
areas representing oedema or cystic degeneration. The imaging 
appearance of thecomas without prominent fibrosis is similar 
to malignant tumors. The prominent lipid component of 
thecomas could be depicted with chemical-shift MR imaging 
[9]. 
The addition of diffusion-weighted imaging (DWI) and 
perfusion weighted imaging (PWI) to conventional MR might 
help to diagnose fibrothecomas [10] especially when the ADC 
map does not show any relevant restricted diffusion areas. 
 
Sometimes ascites and pleural effusions may be present, 
with large fibromas [8]; the presence of normal ovarian tissue 
adjacent to an ovarian lesion is a useful morphological feature 
that can help exclude invasive ovarian malignancy [10]. 
Therefore, the association of pelvic masses with heterogenous 
T2-signal and pelvic intraperitoneal fluid do not necessarily 
imply the presence of a malignant neoplasia, as shown in 
literature, but it is often related to degenerative aspects in the 
largest fibromas and fibrothecomas. 
DISCUSSION 
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Treatment & Prognosis: 
Treatment of this syndrome must be multidisciplinary and 
will depend on the systems affected. Prognosis depends on the 
malignant progression of the lesions; however, life expectancy 
is no different from that of the general population [3]. 
 
Most ovarian fibromas are asymptomatic but when 
sufficiently large, they present with symptoms related to an 
abdominal mass, as gastrointestinal or genitourinary 
symptoms. Rarely, a patient may present with acute symptoms 
secondary to torsion of the fibroma, as has occurred in other 
studies. The decision to perform conservative surgery with 
preservation of ovarian function is problematic. Although 
ovarian malignancies have not been reported with this 
syndrome, Abel and Holtz have reported two ovarian 
fibrosarcomas in a review of 170 adolescents with ovarian 
tumors [12].  
 
In the absence of gynecological symptoms, it seems wisest 
to preserve ovarian function in young patients, as there is no 
reason to sacrifice childbearing capacity. Moreover, fertility 
does not appear to be affected in NBCCS [13]. 
 
Differential Diagnosis: 
Leiomyomas: the distinction of ovarian fibromas and 
uterine leiomyomas may be difficult, as they both present as 
solid hypoechoic masses with ultrasound beam attenuation on 
US; on CT they are hypoattenuating masses with heterogenous 
enhancement after intravenous contrast administration; on 
MRI they both show low-signal either in T1-weighted and T2-
weighted images. A careful detection of the pedicle extending 
toward the uterus, vascular signal voids between the uterus and 
tumor mass, as well as the evaluation of the relationship 
between the ipsilateral ovary, can facilitate the diagnosis [10]. 
 
Germ-cell tumors: on US germ-cell tumors present as non-
specific complex mass with possible calcification; on CT and 
MRI calcifications, cystic components and small foci of fat are 
suggestive. Hemorrhage may be present. In this case these 
calcified solid masses showed no evidence of fat, making 
germ-cell tumors a less-likely diagnosis [14]. 
 
Pelvic metastases: on US they present as mixed 
echogenicity tumors with vascularity of solid component on 
Doppler. On CT they present as soft tissue density with areas 
of cystic necrosis and, after contrast administration, solid 
components demonstrate heterogenous enhancement. On T1-
weighted MRI images they are usually iso to hypointense with 
variable enhancement after contrast administration and on T2-
weighted images they show heterogenous signal of solid 
component with hyperintensity of cystic component. In this 
case, the patient had a history of basal cell carcinoma that 
rarely metastasizes [14]. Metastatic ovarian carcinomas may 
mimic primary ovarian neoplasm both morphologically and 
clinically. Furthermore, the radiological features of metastatic 
ovarian cancer show considerable variability [15]. 
 
In conclusion, we presented the case of a young Caucasian 
woman affected by NBCCS that met three of the diagnostic 
criteria including BCCs, odontogenic keratocysts and ovarian 
fibromas. The use of several  imaging modalities (ultrasound, 
MRI and CT) allowed us to formulate a hypothesis of benign 
uterine and ovarian lesions allowing the patient to have 
laparoscopic fertility-sparing surgery. 
 
  
 
 
The association of pelvic masses with heterogenous T2-signal 
and pelvic intraperitoneal fluid do not necessarily imply the 
presence of a malignant neoplasia but it is often related to 
degenerative aspects in large fibromas and fibrothecomas. In 
the differential diagnosis clinical and radiological features 
must be taken into account globally to identify possible 
Nevoid Basal Cell Carcinoma Syndrome. 
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Figure 1: 25-year-old woman with multiple ovarian and 
uterine fibromas in Nevoid Basal Cell Carcinoma Syndrome. 
Findings: ultrasound imaging highlights the presence of 
heterogenous hypoechoic uterine round-shaped mass 
measuring 65 x 62 x 59 mm adherent to the anterior uterine 
wall (red arrow). Left ovary was appreciable with difficulty 
due to the presence of a rounded hypoechoic mass measuring 
18 x 15 mm (yellow arrow: an ovarian mass). Ovarian follicles 
were not depictable bilaterally.  
Technique: General Electric Voluson E6 (transrectal 
transducer, 4-9 MHz). 
 
 
 
Figure 2 (left): 25-year-old woman 
with multiple ovarian and uterine 
fibromas in Nevoid Basal Cell 
Carcinoma Syndrome. 
 
Findings: Magnetic Resonance shows 
multiple lesions of the uterus and both 
ovaries (red arrows). In left adnexal 
region there are at least four masses, 
with prevalent hypointense signal in 
T2-weighted sequences (a: axial T2-
weighted, b: axial fat-satured T2-
weighted), with little increase in signal 
intensity on higher b values diffusion 
images (red circle) and mild 
heterogenous restricted diffusion on 
ADC map with ADC coefficient of 0.6 
mm2/s (c: Diffusion Weighted 
sequence with different b values: 0, 
330, 660, 1000 s/mm2; d: ADC map). 
 
Technique: Philips Ingenia 1.5 T 
Magnetic Resonance System. Spin 
Echo T2-weighted sequences (TR: 
4050,55 - TE: 110). Fat-satured Spin 
Echo T2-weighted sequences (TR: 
4718,58, TE 100, TI 160). Diffusion-
weighted sequence (TR: 1786,29 - TE: 
90,06). 
 
 
 
FIGURES 
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Figure 3: 25-year-old woman with multiple ovarian and uterine fibromas in Nevoid Basal Cell Carcinoma Syndrome. 
 
Findings: On T2-weighted sequences (a: sagittal plane; b: axial plane; c: coronal plane) the largest lesion adherent to the anterior 
uterine wall shows heterogenous signal (red arrows). ADC map does not show any relevant restricted diffusion areas (d). 
 
Technique: Philips Ingenia 1.5 T Magnetic Resonance System. Spin Echo T2-weighted sequences (TR: 4050,55 - TE: 110); 
Diffusion-weighted sequence (TR: 1786,29 - TE: 90,06). 
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Figure 4: 25-year-old woman with multiple ovarian and uterine fibromas in Nevoid Basal Cell Carcinoma Syndrome. 
 
Findings: On fat-satured T1-weighted sequence before contrast administration, the lesions appear isointense compared to 
myometrium (a: axial plane before contrast administration); after contrast administration (b: axial plane after contrast 
administration; c: coronal plane after contrast administration; d: sagittal plane after contrast administration), the masses show 
heterogenous intense contrast enhancement (red arrows indicate the largest lesion, yellow arrows the smallest masses). 
 
Technique: Philips Ingenia 1.5 T Magnetic Resonance System. Pre and post intravenous contrast administration (contrast agent 
used: Gadolinium-DTPA 0.2 ml/Kg). Fat-satured Gradient Echo T1-weighted sequence before contrast administration (TR: 4; TE 
1,92); fat-satured Gradient Echo T1-weighted sequence after contrast administration (TR: 4; TE 1,92). 
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Figure 5: 25-year-old woman with multiple ovarian and uterine fibromas in Nevoid Basal Cell Carcinoma Syndrome. 
 
Findings: T2-weighted sequences (a: axial plane; b: coronal plane; c: sagittal plane) show a uterine hypointense pedunculated 
mass measuring 30 x 24 x 20 mm. 
 
Technique: Philips Ingenia 1.5 T Magnetic Resonance System. Spin Echo T2-weighted sequences (TR: 4050,55 - TE: 110). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 (left): Computed 
Tomography. 25-year-old woman with 
multiple ovarian and uterine fibromas 
in Nevoid Basal Cell Carcinoma 
Syndrome. 
 
Findings: Computed Tomography 
examination on axial (a: before IV 
contrast administration; b: after 
contrast administration in venous 
phase), sagittal (c) and coronal planes 
(d) demonstrates the presence of 
numerous uterine and ovarian masses 
(red arrows), partially calcified 
(asterisks) on precontrast images 
which show heterogenous contrast-
enhancement. Anteverted uterus, with 
regular zonal anatomy. Small amount 
of fluid in Douglas pouch. Ovarian 
follicles were not depictable 
bilaterally.  
 
Technique: Computed Tomography 
General Electric LightSpeed VCT 
128-slice, 410 mAs, 120 kV, 2.5 mm 
slice thickness, 1.25 mm gap, 120 ml 
Iomeprol 300, DLP 612.48 mGycm. 
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Figure 7: 25-year-old woman with multiple ovarian and uterine fibromas in Nevoid Basal Cell Carcinoma Syndrome. 
 
Findings: laparoscopic image showing the left adnexa with multiple fibroids. 
 
Technique: laparoscopic surgery. 
 
 
Figure 8: 25-year-old woman with multiple ovarian and uterine fibromas in Nevoid Basal Cell Carcinoma Syndrome. 
 
Findings: a) small aggregates of fibroblast cells without cytologic atipies; b) calcifications in the context of cellular aggregates 
and fibrous tissue. 
 
Technique: hematoxylin and eosin 10 x. 
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ETIOLOGY Mutations in the PTCH1 gene 
INCIDENCE 1/57,000 - 1/256,000 
GENDER RATIO No difference 
AGE PREDILECTION Adolescence 
RISK FACTORS No known risk factors 
TREATMENT Surgical resection (if possible, fertility-sparing surgery). 
PROGNOSIS Good 
FINDINGS ON IMAGING Pelvic Fibromas 
CT: mass effect, possible calcifications. MRI: low to intermediate signal in T1w and low signal 
in T2w. In DWI no relevant restricted diffusion areas in ADC map. 
 
Table 2: Summary table for Gorlin-Goltz Syndrome with imaging features of associated pelvic fibromas. 
MAJOR CRITERIA MINOR CRITERIA 
1. Lamellar (sheet-like) calcification of the falx or clear 
evidence of calcification in an individual younger than age 20 
years  
 
1. Childhood medulloblastoma (also called primitive 
neuroectodermal tumor) 
 
2. Odontogenic keratocysts of the jaws proven by 
histopathology 
 
2. Lympho-mesenteric or pleural cysts 
3. Palmar/plantar pits (≥2) 
 
3. Macrocephaly (occipitofrontal head circumference >97th 
centile) 
 
4. Multiple basal cell carcinomas (BCCs) (>5 in a lifetime) or 
a BCC before age 30 years 
 
4. Cleft lip/palate 
 
5. First-degree relative with NBCCS 
 
5. Vertebral/rib anomalies observed on chest x-ray and/or 
spinal x-ray: bifid/splayed/extra ribs; bifid vertebrae 
 
 6. Preaxial or postaxial polydactyly 
 
 7. Ovarian/cardiac fibromas 
 
 8. Ocular anomalies (e.g., cataract, developmental defects, and 
pigmentary changes of the retinal epithelium) 
  
 
Table 1: Criteria for diagnosis of Nevoid Basal Cell Carcinoma Syndrome. 
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 US CT MRI 
FIBROMAS/ 
LEIOMYOMAS/ 
FIBROTHECOMAS 
Variable appearance; 
generally solid, 
hypoechoic masses with 
ultrasound beam 
attenuation. 
Hypoattenuating masses. 
Calcifications and bilaterality 
are both uncommon. 
 
After IV contrast 
administration: heterogenous 
delayed enhancement. 
T1w: low signal. 
T2w: low signal, sometimes 
hyperintense areas representing 
edema or cystic degeneration. 
T1w after contrast administration: 
heterogenous enhancement. 
 
GERM-CELL TUMORS Non-specific complex 
mass with possible 
calcifications. 
Calcifications, cystic 
components and small foci of 
fat are suggestive.  
Hemorrhage may be present. 
 
Calcifications, cystic components and 
small foci of fat are suggestive.  
Hemorrhage may be present. 
 
PELVIC METASTASES Mixed echogenicity 
tumors with vascularity 
of solid component on 
Doppler. 
Soft tissue density with areas of 
cystic necrosis. After contrast 
administration, solid 
components demonstrate 
heterogenous enhancement. 
T1: iso to hypointense with variable 
enhancement after contrast 
administration. 
T2: heterogenous signal of solid 
component with hyperintensity of 
cystic component. 
 
Table 3: Differential diagnosis table for pelvic fibromas. 
 
 
 
 
 
 
 
BCCs = Basal Cell Carcinomas 
CT = Computed Tomography 
DWI = Diffusion Weighted Imaging 
IV = intravenous 
MR = Magnetic Resonance 
MRI = Magnetic Resonance Imaging 
NBCCS = Nevoid Basal Cell Carcinoma Syndrome 
PWI = Perfusion Weighted Imaging 
US = Ultrasound 
 
 
 
 
Gorlin-Goltz syndrome; NBCCS; ovarian fibromas; uterine 
fibromas; MRI 
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